New cancer clinical trial: Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies

Published on: December 31, 2018 at 12:00PM
Condition:   Cancer
Intervention:   Drug: JTX-4014
Sponsor:   Jounce Therapeutics, Inc.
Recruiting
http://bit.ly/2s2tQIG